Wide range of views about switching to weekly, monthly or biannual ART
Efavirenz, but not dolutegravir, linked to neurological problems in children
Doravirine combination works well as a switch option
Dual-antibody combination therapy produces three to seven months of viral suppression without pills
People living with HIV underestimate the harm of smoking
US doctors’ organisation endorses event-based PrEP for the first time
